Pfizer tops quarterly estimates, hikes low end of revenue guidance on strength of non-Covid products
Pfizer tops quarterly estimates, hikes low end of revenue guidance on strength of non-Covid products
Pfizer Inc. signage on the floor of the New York Stock Exchange (NYSE) in New York, US,...
